AirStrip announced that the Food and Drug Administration (FDA) has cleared the AirStrip Sense4Baby wireless maternal/fetal monitoring system for use by pregnant patients to self-administer non-stress tests (NST).
Sense4Baby is a remote, wireless maternal/fetal heart rate monitoring system used to perform non-stress testing (NST) for high-risk pregnancies during the antepartum period that utilizes the AirStrip mobile interoperability platform.
A research study will be conducted by the University of Utah to assess the feasibility of integrating an at-home NST monitoring program with a local high-risk population into an established health care system and to evaluate patient and provider satisfaction.
Sense4Baby previously received FDA clearance in 2013 for use in clinical settings.
For more information visit AirStrip.com.